EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual-Mode Sensing Platform for Cancer Antigen 15-3 Determination Based on a Silica Nanochannel Array Using Electrochemiluminescence and Electrochemistry

Jie Huang, Tongtong Zhang, Yanyan Zheng, Jiyang Liu iD

Biosensors · 2023

DOI: 10.3390/bios13030317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, 2023. Verfasst von Jie Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Surface & Interface Science of Polymer Materials of Zhejiang Province, Department of Chemistry, Zhejiang Sci-Tech University, Hangz…. Hauptthemen laut MEDLINE: Biosensing Techniques, Neoplasms. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An electrochemiluminescence-electrochemistry (ECL-EC) dual-mode sensing platform based on a vertically-ordered mesoporous silica films (VMSF) modified electrode was designed here for the sensitive and selective determination of cancer antigen 15-3 (CA 15-3), a specific biomarker of breast cancer. VMSF was assembled through a rapid electrochemically assisted self-assembly (EASA) method and plays a crucial role in signal amplification via a strong electrostatic interaction with the positively charged bifunctional probe Ru(bpy)32+. To construct the biorecognition interface, epoxy functional silane was linked to the surface of VMSF for further covalent immobilization of the antibody. As a benefit from the specific combination of antigen and antibody, a non-conductive immunocomplex layer was formed in the presence of CA 15-3, leading to the hinderance of the mass and electron transfer of the probes. Based on this strategy, the dual-mode determination of CA 15-3 ranging from 0.1 mU/mL to 100 mU/mL with a LOD of 9 μU/mL for ECL mode, and 10 mU/mL to 200 U/mL with a LOD of 5.4 mU/mL for EC mode, was achieved. The proposed immunosensor was successfully employed for the detection of CA 15-3 in human serum without tedious pretreatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesNeoplasmsHumansLuminescent MeasurementsSilicon DioxideElectrochemistryImmunoassayAntibodies

Stichwörter der Autor:innen

cancer antigen 15-3dual-mode detectionelectrochemiluminescenceelectrochemistryimmunosensorvertically ordered mesoporous silica film

Substanzen

Silicon DioxideAntibodies

Autor:innen und Institutionen

  • Key Laboratory of Surface & Interface Science of Polymer Materials of Zhejiang Province, Department of Chemistry, Zhejiang Sci-Tech University, Hangzhou 310018, China.
  • Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicin…

ORCID-Profile: Jiyang Liu

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation

Zitieren

APA

Huang, J., Zhang, T., Zheng, Y., & Liu, J. (2023). Dual-Mode Sensing Platform for Cancer Antigen 15-3 Determination Based on a Silica Nanochannel Array Using Electrochemiluminescence and Electrochemistry. Biosensors. https://doi.org/10.3390/bios13030317

Vancouver

Huang J, Zhang T, Zheng Y, Liu J. Dual-Mode Sensing Platform for Cancer Antigen 15-3 Determination Based on a Silica Nanochannel Array Using Electrochemiluminescence and Electrochemistry. Biosensors. 2023. doi:10.3390/bios13030317

BibTeX
@article{Huang2023,
  author = {Huang, Jie and Zhang, Tongtong and Zheng, Yanyan and Liu, Jiyang},
  title = {Dual-Mode Sensing Platform for Cancer Antigen 15-3 Determination Based on a Silica Nanochannel Array Using Electrochemiluminescence and Electrochemistry},
  journal = {Biosensors},
  year = {2023},
  doi = {10.3390/bios13030317}
}
Kostenlos starten →